S14-258 Using Bispecific Antibodies to Target Cancer Cells for Phagocytic Removal Stanford scientists have discovered that bispecific antibodies can selectively bind cancer cells and block the CD47-SIRPα "don't eat me signal" to efficiently clear tumors with negligible toxicity. Ravindra Majeti Emily Piccione Griffin
S20-364 New Immunotherapeutic Target for the Treatment of Lung Cancer and Fibrotic Lung Diseases Stanford scientists have discovered a new immunotherapeutic target for treating lung cancer and fibrotic lung disease. Gerlinde Wernig Tristan Lerbs Lu Cui Qiwen Deng Cristabelle De Souza